Apellis Pharmaceuticals (APLS) PEG Ratio
Market Cap: $2.44B
Avg Volume: 1.95M
Industry: Biotechnology
Sector: Healthcare
PEG Ratio Summary
- Apellis Pharmaceuticals's trailing twelve month (TTM) PEG ratio is -0.56.
- Apellis Pharmaceuticals's annual PEG ratio as of today is 0.31.
- Apellis Pharmaceuticals's quarterly PEG ratio is 0.74.
What is the PEG Ratio?
The PEG ratio (Price/Earnings to Growth ratio) is a valuation metric for determining the relative trade-off between the price of a stock, the earnings generated per share (EPS), and the company's expected growth. A lower PEG ratio suggests that a stock may be undervalued given its earnings performance and growth potential.
How is the PEG Ratio calculated?
The PEG ratio is calculated by dividing the P/E ratio by the annual EPS growth. The formula is:
PEG Ratio = (P/E Ratio) / (EPS Growth Rate)
This helps investors to determine a stock's value while considering the company's earnings growth.
Related Metrics
Other important metrics to assess Apellis Pharmaceuticals's financial health include:
- P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
- Annual: -19.98
- Quarterly: -27.19
- TTM: -12.16
- P/S Ratio (Price to Sales Ratio) - compares the company's stock price to its revenues:
- Annual: 5.57
- Quarterly: 18.60
- TTM: 3.12
- P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
- Annual: 17.30
- Quarterly: 17.30
- TTM: 10.53
- P/CF Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
- Annual: -45.00
- Quarterly: 204.22
- TTM: -27.39
These metrics provide insights into Apellis Pharmaceuticals's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
TTM PEG Ratio
-0.56
Annual PEG Ratio
0.31
Quarterly PEG Ratio
0.74
Apellis Pharmaceuticals Historical PEG Ratio
Historical P/E Ratio
Historical P/S Ratio
Historical P/B Ratio
Historical P/CF Ratio
Apellis Pharmaceuticals Historical Financial Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | PEG Ratio | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|---|
| 2024 | 0.31 | -19.98 | 5.57 | 17.30 | -45.00 |
| 2023 | 0.49 | -13.44 | 17.91 | 36.52 | -11.94 |
| 2022 | 0.28 | -8.41 | 72.75 | 32.30 | -10.68 |
| 2021 | -0.06 | -5.35 | 59.96 | 20.09 | -7.09 |
| 2020 | 1.59 | -12.47 | 17.15 | 21.02 | -26.79 |
| 2019 | -0.05 | -6.15 | 0.00 | 55.67 | -9.02 |
| 2018 | 0.15 | -5.63 | 0.00 | 4.46 | -5.47 |
| 2017 | -0.04 | -5.90 | 0.00 | 2.02 | -6.46 |
| 2016 | 0.22 | -9.36 | 0.00 | 10.67 | -9.76 |
| 2015 | -0.02 | -5.46 | 0.00 | 7.26 | -13.46 |
| 2014 | -0.14 | -23.53 | 0.00 | 19.19 | -25.52 |
| 2013 | 0.00 | -64.08 | 0.00 | 56.13 | -73.69 |
Related Metrics
Explore detailed financial metrics and analysis for APLS.